In a world where many businesses have shaky balance sheets, some have ignored the crowd and exercised prudence. These cash-heavy companies shine bright for their financial discipline, resilience, and ability to generate solid returns.
Not all companies with sound capital structures are created equal, and StockStory is here to help you find the best. Keeping that in mind, here are three companies with net cash positions that can leverage their balance sheets to grow.
Remitly (RELY)
Net Cash Position: $609.8 million (15.4% of Market Cap)
With Amazon founder Jeff Bezos as an early investor, Remitly (NASDAQ: RELY) is an online platform that enables consumers to safely and quickly send money globally.
Why Are We Bullish on RELY?
- Has the opportunity to boost monetization through new features and premium offerings as its active customers have grown by 28.4% annually over the last two years
- Performance over the past three years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 247% outpaced its revenue gains
- Free cash flow margin jumped by 35.2 percentage points over the last few years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
Remitly is trading at $24.38 per share, or 11.5x forward EV/EBITDA. Is now the right time to buy? See for yourself in our full research report, it’s free.
Vertex Pharmaceuticals (VRTX)
Net Cash Position: $5.26 billion (4.7% of Market Cap)
Founded in 1989 with a mission to create medicines that treat the underlying causes of disease rather than just symptoms, Vertex Pharmaceuticals (NASDAQ: VRTX) develops and markets transformative medicines for serious diseases, with a focus on cystic fibrosis, sickle cell disease, and pain management.
Why Does VRTX Catch Our Eye?
- Offerings and unique value proposition resonate with customers, as seen in its above-market 13.8% annual sales growth over the last five years
- VRTX is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders
- ROIC punches in at 49.4%, illustrating management’s expertise in identifying profitable investments
Vertex Pharmaceuticals’s stock price of $519.62 implies a valuation ratio of 27x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Ameriprise Financial (AMP)
Net Cash Position: $4.86 billion (12% of Market Cap)
Founded in 1894 and spun off from American Express in 2005, Ameriprise Financial (NYSE: AMP) provides financial planning, wealth management, asset management, and insurance products to help individuals and institutions achieve their financial goals.
Why Is AMP a Top Pick?
- Performance over the past five years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
- Balance sheet strength has increased this cycle as its 18.7% annual tangible book value per share growth over the last two years was exceptional
- Market-beating return on equity illustrates that management has a knack for investing in profitable ventures
At $504.76 per share, Ameriprise Financial trades at 11x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
